EUVIMEDEUVIMED entdecken
Crossref

mTORC2‐AKT signaling to PFKFB2 activates glycolysis that enhances stemness and tumorigenicity of intestinal epithelial cells

Mengzhen Li iD, Xi Wu iD, Yuwei Pan, Manyu Song, Xu Yang, Jiuzhi Xu, Maksim V Plikus iD, Cong Lv, Lu Yu iD, Zhengquan Yu iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202301833rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Mengzhen Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Neoplasms, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although elevated glycolysis has been widely recognized as a hallmark for highly proliferating cells like stem cells and cancer, its regulatory mechanisms are still being updated. Here, we found a previously unappreciated mechanism of mammalian target of rapamycin complex 2 (mTORC2) in regulating glycolysis in intestinal stem cell maintenance and cancer progression. mTORC2 key subunits expression levels and its kinase activity were specifically upregulated in intestinal stem cells, mouse intestinal tumors, and human colorectal cancer (CRC) tissues. Genetic ablation of its key scaffolding protein Rictor in both mouse models and cell lines revealed that mTORC2 played an important role in promoting intestinal stem cell proliferation and self‐renewal. Moreover, utilizing mouse models and organoid culture, mTORC2 loss of function was shown to impair growth of gut adenoma and tumor organoids. Based on these findings, we performed RNA‐seq and noticed significant metabolic reprogramming in Rictor conditional knockout mice. Among all the pathways, carbohydrate metabolism was most profoundly altered, and further studies demonstrated that mTORC2 promoted glycolysis in intestinal epithelial cells. Most importantly, we showed that a rate‐limiting enzyme in regulating glycolysis, 6‐phosphofructo‐2‐kinase (PFKFB2), was a direct target for the mTORC2‐AKT signaling. PFKFB2 was phosphorylated upon mTORC2 activation, but not mTORC1, and this process was AKT‐dependent. Together, this study has identified a novel mechanism underlying mTORC2 activated glycolysis, offering potential therapeutic targets for treating CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsProto-Oncogene Proteins c-aktAnimalsHumansMiceDisease Models, AnimalEpithelial CellsGlycolysisMammalsMechanistic Target of Rapamycin Complex 2Mice, KnockoutPhosphofructokinase-2Sirolimus

Stichwörter der Autor:innen

PFKFB2glycolysisintestinal stem cellsmTORC2tumorigenesis

Substanzen

Mechanistic Target of Rapamycin Complex 2PFKFB2 protein, humanPhosphofructokinase-2Proto-Oncogene Proteins c-aktSirolimusPfkfb2 protein, mouse

Autor:innen und Institutionen

  • Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing, China.
  • Department of Developmental and Cell Biology, Sue and Bill Gross Stem Cell Research Center, Center for Complex Biological Systems, University of California, Irvine, Irvine, California, USA.
  • Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, Department of Nutrition and Health, China Agricultural University, Beijing, China.

ORCID-Profile: Mengzhen Li, Xi Wu, Maksim V Plikus, Lu Yu, Zhengquan Yu

Förderung

  • the National Key Research and Development Program of China
  • the National Natural Science Foundation of China

Zitieren

APA

Li, M., Wu, X., Pan, Y., Song, M., Yang, X., Xu, J., Plikus, M. V., Lv, C., Yu, L., & Yu, Z. (2024). mTORC2‐AKT signaling to PFKFB2 activates glycolysis that enhances stemness and tumorigenicity of intestinal epithelial cells. The FASEB Journal. https://doi.org/10.1096/fj.202301833rr

Vancouver

Li M, Wu X, Pan Y, Song M, Yang X, Xu J, et al. mTORC2‐AKT signaling to PFKFB2 activates glycolysis that enhances stemness and tumorigenicity of intestinal epithelial cells. The FASEB Journal. 2024. doi:10.1096/fj.202301833rr

BibTeX
@article{Li2024,
  author = {Li, Mengzhen and Wu, Xi and Pan, Yuwei and Song, Manyu and Yang, Xu and Xu, Jiuzhi and Plikus, Maksim V and Lv, Cong and Yu, Lu and Yu, Zhengquan},
  title = {mTORC2‐AKT signaling to PFKFB2 activates glycolysis that enhances stemness and tumorigenicity of intestinal epithelial cells},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202301833rr}
}
Kostenlos starten →